TOM1 and carcinoma: First, in terms of immune function, variations related to the nuclear factor kappa B (NF-κB) signaling pathway (NLRP12, TNIP2, IRAK4) and the autophagy process (TECPR1, ATG2A, SOGA1, TOM1) were identified in both carcinoma and sarcoma tumor groups.